Cargando…
Comment on “Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systematic Review”
Autores principales: | Delicata, Nicholas-Paul, Azzopardi, Neville, Ellul, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904624/ https://www.ncbi.nlm.nih.gov/pubmed/27443947 http://dx.doi.org/10.1155/2016/3238925 |
Ejemplares similares
-
Comment on “Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease”
por: Lai, Wenwen, et al.
Publicado: (2018) -
Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease
por: Moayyedi, Paul, et al.
Publicado: (2020) -
Comment on “Do biomarkers have predictive value in the treatment modality of the patients diagnosed with bowel obstruction?”
por: Cao, Shuang, et al.
Publicado: (2022) -
Proton Pump Inhibitors in the Management of Tachypnoea following Panproctocolectomy: A Case of High Output Ileostomy
por: Azzopardi, Neville, et al.
Publicado: (2011) -
Comment on “Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy”
por: Argyriou, Konstantinos, et al.
Publicado: (2022)